Cosmetic containing 4-tert-butyl cyclohexanol and ectoine
By using 4-tert-butylcyclohexanol and ektoin in cosmetics and combining natural glue as thickeners, the problem of pilling effect in cosmetics is solved, achieving better care effects and user experience.
Patent Information
- Application Number
- CN202411452536.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-10-17
- Filing Date
- 2024-10-17
- Publication Date
- 2025-04-18
AI Technical Summary
Polymers and emulsifier ingredients commonly used in existing cosmetics lead to pilling effects, affecting the skin's care effect and user experience.
A cosmetic composition containing 4-tert-butylcyclohexanol and ektoin is used, combined with natural glue as a thickener, to form an emulsion preparation with an aqueous and oily phase to reduce the pilling effect.
It effectively reduces the pilling effect of cosmetics on the skin, improves the user experience and effect of care products, and avoids the possible side effects of traditional ingredients.
Smart Images

Figure BDA0005089563450000151 
Figure BDA0005089563450000161 
Figure BDA0005089563450000171
Abstract
Description
Technical Field
[0001] The invention belongs to the field of cosmetics and relates to a cosmetic composition containing 4-tert-butyl cyclohexanol and ectoine. Background Art
[0002] Cosmetics generally not only contribute to looking beautiful and attractive, but their effects decisively contribute to enhancing self-esteem and people's sense of well-being. Therefore, a wide variety of cosmetics are used for the daily cleansing and care of human skin.
[0003] One well-known category of cosmetics is body lotions and cosmetic facial care products. These preparations are usually formulated as oil-in-water emulsions or in the form of gels.
[0004] Many consumers have had the experience of using cosmetic body lotions and facial care products: small balls appear on the skin after completing their daily skin care routine. In many cases, this is described as the pilling effect. This is very frustrating for consumers because in many cases, they have to remove these balls or small balls to make their skin look clean and flawless.
[0005] In general, the occurrence of pilling can be controlled by careful selection of the ingredients included in the formulation. For example, pilling has been found to increase with increasing polymer molecular weight and with increasing amounts of these polymers in the formulation. Powders like silica or starch may further increase the risk of pilling when used with these polymers.
[0006] The most commonly used polymers in body lotions and cosmetic facial care products are polymers formed by homopolymerization or copolymerization using acrylic acid, methacrylic acid and / or vinyl pyrrolidone. Due to their properties, they can be used at low molecular weights and generally only limited amounts of these polymers are required to provide a formulation with adequate rheological properties. In addition, silicone oils and / or silicone derivatives provide a silky feel, which may also help to reduce friction on the skin when applying the care product to the skin. Silicone derivatives are considered to contain [R 1 R 2 SiO] n Subunit chemical substances, where R 1 and R 2 Each is an alkyl group, and n may be 1 or greater. Thus, in these formulations, the effect of pilling can be conveniently controlled.
[0007] However, for various reasons, it is desirable to provide formulations that are free of silicones and polymers homopolymerized or copolymerized with acrylic acid, methacrylic acid and / or vinylpyrrolidone. For example, the biodegradability of these compounds has not been fully investigated, so consumers are no longer interested in using products containing these ingredients. Although this approach sounds simple, the problem of pilling is becoming increasingly important for such formulations.
[0008] Another aspect is that prior art formulations often contain polyethylene glycol derivatives as emulsifiers, such as PEG-40 hydrogenated castor oil. Polyethylene glycol derivatives are considered to contain at least one (-CH2-CH2-O-) i The molecule of the unit wherein i is an integer of 2 or greater. However, consumers prefer to use formulations that do not contain polyethylene glycol derivatives because they are concerned that these ingredients may cause undesirable side effects. As a result, the number of ingredients that can be used to reduce the pilling effect is further reduced.
[0009] Therefore, it remains desirable to provide formulations and mechanisms to control and reduce pilling that do not rely on the above ingredients.
[0010] 4-tert-Butylcyclohexanone is an ingredient occasionally used in cosmetic preparations. This ingredient is sold under the trade name 1609 is sold as a clear synthetic liquid solution for rapid skin relief. It provides significant relief from stinging and burning, with up to 78% less stinging after 3 minutes and up to 80% less burning after 3 minutes. It has been shown to calm scalp burning and stinging sensitivity during chemical hair color treatments. In addition to 4-tert-butylcyclohexanone, 1609 also contains pentylene glycol.
[0011] Ectoin is used as an active ingredient in skin care and sunscreen products. It stabilizes proteins and other cell structures, protecting the skin from stressors such as UV exposure and dryness.
[0012] WO2009 / 087242A2 discloses a cosmetic preparation containing 4-tert-butyl cyclohexanol. US20010021388A1 discloses the cosmetic use of ectoine. However, these documents cannot lead those skilled in the art to the direction of the present invention.
[0013] It has now surprisingly been found that the present invention can be used to reduce the pilling effect in cosmetic products. Summary of the invention
[0014] A first object of the present invention is a cosmetic composition comprising an aqueous phase and an oil phase, and wherein, based on the total weight of the composition, the composition comprises:
[0015] a) 0.01% to 1% by weight of 4-tert-butyl cyclohexanol,
[0016] b) 0.01% to 1.0% by weight of ectoine,
[0017] c) 75.0% to 95% by weight of water,
[0018] The composition contains no polymers polymerized from a mixture comprising or consisting of acrylic acid, methacrylic acid and / or vinyl pyrrolidone, and the composition contains no silicone oil.
[0019] A second object of the present invention is the use of 4-tert-butyl cyclohexanol and ectoine in a cosmetic composition comprising an oil phase and an aqueous phase to reduce the pilling effect of the composition on human skin, wherein the composition preferably does not contain a polymer polymerized from a mixture comprising or consisting of acrylic acid, methacrylic acid and / or vinyl pyrrolidone, and the composition does not contain silicone oil.
[0020] It has further surprisingly been noted that the present invention allows to reduce the pilling effect, especially in connection with the presence of natural gum as thickener in the formulation.
[0021] definition
[0022] Unless otherwise stated, all weight percentages (wt. %) given below are relative to the total weight of the cosmetic composition.
[0023] If ratios of certain components are disclosed in the following description, these ratios refer to weight ratios of the components unless otherwise specified.
[0024] Unless otherwise stated, all tests and measurements are carried out under “normal conditions”. The term “normal conditions” means 25°C, 1013 hPa and 50% relative humidity.
[0025] In the following description, the terms "according to the invention", "preferred according to the invention" etc. always refer to the uses according to the invention, the compositions and the methods according to the invention.
[0026] For the purpose of this disclosure, the term "free of" means that the proportion of the corresponding substance is less than 0.01% by weight. This ensures that inclusions or impurities accompanying these substances are not considered as "free of" for the present invention.
[0027] The term "skin" refers only to human skin.
[0028] If viscosity values are given in the present disclosure, all values relate to measurement results at 25°C using a Rheomat R 123 from proRheo GmbH in a 150 ml wide-mouth bottle (VWR number: 807-001). The Rheomat R 123 from proRheo GmbH is a rotational viscometer, i.e. the measuring body rotates in the substance to be measured. The force required to rotate the measuring body in the sample at a specified speed is measured. The viscosity is calculated from this torque, the speed of the measuring body and the geometric dimensions of the measuring system used. As measuring body, measuring body No. 1 (article number 200 0191) is used, which is suitable for a viscosity range of up to 10,000 [mPa·s] and a speed range of 62.5 min. -1 .
[0029] Emulsifiers are to be understood as all substances listed under the name "emulsifiers" in the International Cosmetic Ingredient Dictionary and Handbook, 13th edition, 2010, (ISBN 1-882621-47-6). Surfactants are to be understood as all substances listed under the name "surfactants" in the International Cosmetic Ingredient Dictionary and Handbook, 13th edition, 2010, (ISBN 1-882621-47-6).
[0030] Detailed Description
[0031] The composition according to the present invention comprises 4-tert-butyl cyclohexanol. Preferably, the total amount of 4-tert-butyl cyclohexanol is in the range of 0.05 wt % to 1.0 wt %, more preferably 0.1 wt % to 0.8 wt %, most preferably 0.15 wt % to 0.3 wt %, based on the total weight of the composition.
[0032] 4-tert-butyl cyclohexanol can be used in cis or trans variants. According to the present invention, in a preferred case, the composition comprises trans-4-tert-butyl cyclohexanol. In a particularly preferred case, the total amount of trans-4-tert-butyl cyclohexanol is in the range of 0.05 wt % to 1.0 wt %, more preferably 0.1 wt % to 0.8 wt %, most preferably 0.15 wt % to 0.3 wt %, based on the total weight of the composition.
[0033] In the case of containing both cis-4-tert-butyl cyclohexanol and trans-4-tert-butyl cyclohexanol, preferably, the weight ratio between cis-4-tert-butyl cyclohexanol and trans-4-tert-butyl cyclohexanol is in the range of 100:1 to 1:100, more preferably 10:1 to 1:99, most preferably 1:1 to 1:98.
[0034] The composition according to the present invention comprises ectoine. Preferably, the total amount of ectoine is in the range of 0.05 wt % to 0.9 wt %, more preferably 0.1 wt % to 0.8 wt %, most preferably 0.15 wt % to 0.4 wt %, based on the total weight of the composition.
[0035] According to the present invention, preferably, the weight ratio between the total amount of 4-tert-butyl cyclohexanol and ectoine is in the range of 10:1 to 1:10, more preferably 3:1 to 1:3, most preferably 1:1 to 1:2.
[0036] In a further preferred case, the total amount of the oil phase in the cosmetic composition is in the range of 0.1 wt % to 5.0 wt %, more preferably 0.2 wt % to 2.5 wt %, most preferably 0.3 wt % to 2.0 wt %, based on the total weight of the composition. By definition, the total amount of emulsifiers and surfactants is not included in the amount of the oil phase.
[0037] According to the present invention, in preferred cases, the oil phase comprises at least one additional branched alcohol having 14 to 26 carbon atoms. In preferred cases, the at least one additional branched alcohol is selected from alcohols having 16 to 24 carbon atoms, more preferably 18 to 22 carbon atoms, most preferably 20 carbon atoms.
[0038] In one embodiment of the present invention, preferably, the total amount of the at least one additional branched alcohol having 14 to 26 carbon atoms is in the range of 0.1 wt. % to 5.0 wt. %, more preferably 0.2 wt. % to 2.0 wt. %, most preferably 0.3 wt. % to 1.8 wt. %, based on the total weight of the composition.
[0039] In one embodiment of the present invention, preferably, the total amount of the at least one additional branched alcohol having 16 to 24 carbon atoms is in the range of 0.1 wt.% to 5.0 wt.%, more preferably 0.2 wt.% to 2.0 wt.%, most preferably 0.3 wt.% to 1.8 wt.%, based on the total weight of the composition.
[0040] In one embodiment of the present invention, preferably, the total amount of the at least one additional branched alcohol having 18 to 22 carbon atoms is in the range of 0.1 wt. % to 5.0 wt. %, more preferably 0.2 wt. % to 2.0 wt. %, most preferably 0.3 wt. % to 1.8 wt. %, based on the total weight of the composition.
[0041] In one embodiment of the present invention, preferably, the total amount of the at least one additional branched alcohol having 20 carbon atoms is in the range of 0.1 wt. % to 5.0 wt. %, more preferably 0.2 wt. % to 2.0 wt. %, most preferably 0.3 wt. % to 1.8 wt. %, based on the total weight of the composition.
[0042] Preferred examples of these alcohols are octyl dodecanol and / or hexyl decanol. Octyl dodecanol is most preferred.
[0043] A preferred embodiment of the present invention is characterized in that the total amount of alcohols chosen from octyldodecanol and / or hexyldecanol is in the range of 0.1 wt.-% to 5.0 wt.-%, more preferably 0.2 wt.-% to 2.0 wt.-%, most preferably 0.3 wt.-% to 1.8 wt.-%, based on the total weight of the composition.
[0044] According to the present invention, in a further preferred case, the composition comprises an additional oil compound in addition to the silicone oil. The additional oil compound can be selected from additional natural oils or synthetic oils.
[0045] One oil that may be present according to the invention is chosen from esters of linear or branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms and linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms, said esters being hydroxylated. Preferred esters of linear or branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms and linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms (which may be hydroxylated) are selected from the group consisting of hexyldecyl stearate, hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl stearate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl isostearate, isopropyl oleate, isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate, cetearyl isononanoate, 2-ethylhexyl laurate, isostearyl 2-Ethylhexyl Cocoate, 2-Ethylhexyl Cocoate, 2-Octyldodecyl Palmitate, 2-Butyloctanoate, Diisotridecyl Acetate, Ethyl Stearate, Methyl Stearate, Propyl Stearate, Butyl Stearate, Ethyl Myristate, Ethyl Palmitate, Butyl Palmitate, Propyl Stearate, Propyl Palmitate, Stearyl Benzoate, Benzyl Palmitate, Benzyl Stearate, Palmityl Benzoate, C12-15 Alkyl Benzoate, Palmityl Acetate, n-Butyl Stearate, n-Hexyl Laurate, n-Decyl Oleate, Oleyl Oleate, Oleyl Erucate, Erucyl Oleate, Erucyl Erucate, Ethyl Dioleate and Ethyl Dipalmitate.
[0046] Further preferably, at least one fatty acid triglyceride is contained in the composition. Preferably, the fatty acid triglyceride is selected from coconut (Cocos Nucifera) oil (triglyceride (fractionated coconut oil)), Astrocaryum Murumuru seed fat (Astrocaryum sp triglyceride), C10-18 triglyceride, C10-40 isoalkyl acid triglyceride, C12-18 acid triglyceride, C18-36 acid triglyceride, C8-12 acid triglyceride, caprylic / capric / myristic / stearic acid triglyceride, caprylic / capric triglyceride, capric / lauric / myristic / oleic acid triglyceride, caprylic / capric / linoleic acid triglyceride, caprylic / capric / stearic acid triglyceride, castor oil maleate (Ceraphyl RMT (castor oil monomaleate triglyceride), hydrogenated C12-18 triglyceride, lauric acid / palmitic acid / oleic acid triglyceride, mink acid / palmitic acid triglyceride, oleic acid / linoleic acid triglyceride, oleic acid / palmitic acid / lauric acid / myristic acid / linoleic acid triglyceride, ricinoleic acid / caproic acid / capric acid triglyceride, caprylic acid / capric acid / succinic acid triglyceride and / or jojoba oil / caprylic acid / capric acid triglyceride.
[0047] The fatty acid triglycerides may also be part of a natural oil. Preferred natural oils that may be present are coconut oil, (sweet) almond oil, walnut oil, peach kernel oil, almond oil, avocado oil, tea tree oil, soybean oil, soybean oil, sesame oil, sunflower seed oil, camellia oil, evening primrose oil, rice bran oil, palm kernel oil, mango kernel oil, azalea oil, thistle oil, macadamia oil, grape seed oil, amaranth oil, argan oil, bamboo oil, olive oil, wheat germ oil, pumpkin seed oil, mallow oil, hazelnut oil, safflower oil, rapeseed oil, camellia oil, jojoba oil, rambutan oil, cocoa butter and shea butter.
[0048] Further compounds which may be present in the oil phase are, for example, selected from further branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols, since they are obtainable by the Guerbet reaction. Preferred alcohol oils are hexyldecanol ( G 16, T 16), Octyldodecanol ( G, 20) and 2-ethylhexanol.
[0049] Preferred additional oils according to the invention are selected from addition products of 1 to 5 propylene oxide units with mono- or poly-C8-22 alkanols (e.g. caprylic alcohol, capric alcohol, caprylic glycol, lauryl alcohol, myristyl alcohol and stearyl alcohol), for example, PPG-2 myristyl ether and PPG-3 myristyl ether ( APM).
[0050] Additional oils that may be contained in the composition according to the invention are selected from addition products of at least 6 ethylene oxide and / or propylene oxide units with mono- or poly-C3-22 alkanols, such as butanol, butylene glycol, myristyl alcohol and stearyl alcohol, such as PPG-14 butyl ether (Ucon AP), PPG-9 butyl ether ( B25), PPG-10 Butylene Glycol ( 57) and PPG-15 stearyl ether ( E).
[0051] The additional oil is preferably selected from C8-C22 fatty alcohol esters of mono- or polybasic C2-C7 hydroxycarboxylic acids, in particular esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid. Such esters based on linear C14 / 15 alkanols, such as C12-C15 alkyl lactates, and such esters based on C12 / 13 alkanols branched at the 2-position are commercially available from Nordmann, Rassmann GmbH & Co., Hamburg, Germany, under the trade name Especially commercial products ESI, EMI and ETI.
[0052] Additional oils which may preferably be used are selected from the group consisting of symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, for example glycerol carbonate, dioctyl carbonate ( CC) or the esters according to DE 197 56 454 A1.
[0053] Furthermore, in a preferred case, the composition comprises at least one fatty alcohol comprising from 12 to 22 carbon atoms. Among these fatty alcohols, cetyl alcohol, stearyl alcohol and the corresponding mixtures cetearyl alcohol are most preferred.
[0054] A preferred embodiment of the present invention is also preferably characterized by containing at least one polysaccharide as a structuring agent for the composition. According to the present invention, in a preferred case, the polysaccharide is a gum.
[0055] Preferred gums that can be used according to the invention are selected from xanthan gum, gellan gum, sclerotium gum and dehydrogenated xanthan gum.
[0056] Advantageously, the composition comprises 0.1% to 1.5% by weight, more preferably 0.15% to 1.0% by weight, most preferably 0.3% to 0.8% by weight of at least one polymer selected from xanthan gum, gellan gum, sclerotium gum and dehydrogenated xanthan gum, based on the total weight of the composition. In a particularly preferred case, xanthan gum is contained, and the total amount of xanthan gum is in the range of 0.1% to 1.5% by weight, more preferably 0.15% to 1.0% by weight, most preferably 0.3% to 0.8% by weight, based on the total weight of the composition.
[0057] In a particularly preferred case, at least xanthan gum is contained. In a particularly preferred case, xanthan gum is contained in a total amount ranging from 0.1 wt % to 1.5 wt %, more preferably from 0.15 wt % to 1.0 wt %, most preferably from 0.3 wt % to 0.8 wt %, based on the total weight of the composition.
[0058] Further preferred compositions of the present invention comprise hydroxypropyl starch phosphate. For containing hydroxypropyl starch phosphate, preferably, based on the total weight of the composition, the total amount of hydroxypropyl starch phosphate is in the range of 0.01 wt % to 2.5 wt %, more preferably 0.4 wt % to 2.4 wt %, most preferably 0.5 wt % to 1.9 wt %.
[0059] According to the present invention, in a preferred case, the composition is characterized in that the composition is an emulsion. In a preferred case, the composition is an oil-in-water emulsion.
[0060] The composition of the present invention may preferably also comprise an emulsifier system to further stabilize the oil phase and avoid oil separation.
[0061] In one embodiment, the composition comprises at least one polyglycerol ester as an emulsifier. Polyglycerol esters are understood to be esters formed from polyglycerol (eg polyglycerol-10) and at least one monobasic or polybasic fatty acid.
[0062] According to the present invention, preferably, based on the total weight of the composition, the total amount of polyglycerol esters is in the range of 0.1 wt % to 2.0 wt %, more preferably 0.3 wt % to 1.5 wt %, most preferably 0.5 wt % to 1.0 wt %.
[0063] In one embodiment, one or more polyglycerol esters are selected from the esters made by the polyglycerol containing 5 to 15 subunits and the monobasic fatty acids comprising 16 to 20 carbon atoms. In a more preferred embodiment, one or more polyglycerol esters are selected from the esters made by the polyglycerol containing 7 to 12 subunits and the monobasic fatty acids comprising 16 to 20 carbon atoms.
[0064] In another embodiment of the present invention, in a preferred case, one or more polyglycerol esters are selected from: polyglyceryl-10 dimyristate, polyglyceryl-10 diisostearate, polyglyceryl-10 distearate, polyglyceryl-10 dioleate, polyglyceryl-10 dilaurate, polyglyceryl-10 dipalmitate, polyglyceryl-10 nonaisostearate, polyglyceryl-10 heptastearate, polyglyceryl-10 heptaoleate, polyglyceryl-10 myristate, polyglyceryl-10 tristearate, polyglyceryl-10 trioleate, polyglyceryl-10 behenate / glyceryl behenate (eico sadioate), polyglyceryl-10 ethylhexanoate, polyglyceryl-10 macadamia oleate, polyglyceryl-10 isostearate, polyglyceryl-10 stearate, polyglyceryl-10 oleate, polyglyceryl-10 pentaoleate, polyglyceryl-10 isostearate, polyglyceryl-10 stearate, polyglyceryl-10 oleate, polyglyceryl-10 laurate, polyglyceryl-2 distearate, polyglyceryl-2 dioleate, polyglyceryl-2 caprate, polyglyceryl-2 triisostearate, polyglyceryl-2 tetraisostearate, polyglyceryl-2 tetraoleate, polyglyceryl-2 isostearate fatty acid ester, polyglyceryl-2 isopalmitate, polyglyceryl-2 stearate, polyglyceryl-2 oleate, polyglyceryl-2 laurate, polyglyceryl-3 ricinoleate, polyglyceryl-3 diisostearate, polyglyceryl-3 distearate, polyglyceryl-3 beeswax, polyglyceryl-3 caprate, polyglyceryl-3 polyricinoleate, polyglyceryl-3 myristate, polyglyceryl-3 pentaricinoleate, polyglyceryl-3 caprylate, polyglyceryl-3 cocoate, polyglyceryl-3 isostearate, polyglyceryl-3 stearate, polyglyceryl-3 oleate, polyglyceryl-3 laurate, polyglyceryl-3 palmitate, Polyglyceryl-4 dilaurate, polyglyceryl-4 caprate, polyglyceryl-4 isostearate, polyglyceryl-4 stearate, polyglyceryl-4 oleate, polyglyceryl-4 laurate, polyglyceryl-5 myristic acid, polyglyceryl-5 trioleate, polyglyceryl-5 isostearate, polyglyceryl-5 stearate, polyglyceryl-5 oleate, polyglyceryl-5 laurate, polyglyceryl-6 caprylate, polyglyceryl-6 isostearate, polyglyceryl-6 stearate, polyglyceryl-6 oleate, polyglyceryl-6 laurate, polyglyceryl-8 stearate and / or selected from polyglyceryl-3 methylglucose distearate.
[0065] In one embodiment, in preferred cases, the composition comprises polyglyceryl-10 stearate, polyglyceryl-10 myristate, polyglyceryl-6 laurate, polyglyceryl-8 stearate and / or polyglyceryl-3 methyl glucose distearate. In this embodiment, in preferred cases, the total amount of polyglyceryl-10 stearate, polyglyceryl-10 myristate, polyglyceryl-6 laurate, polyglyceryl-8 stearate and / or polyglyceryl-3 methyl glucose distearate is in the range of 0.1 wt % to 2.0 wt %, more preferably 0.3 wt % to 1.5 wt %, most preferably 0.5 wt % to 1.0 wt %, based on the total weight of the composition.
[0066] Preferably, the total amount of polyglycerol esters is in the range of 0.1 wt% to 2.0 wt%, more preferably 0.3 wt% to 1.5 wt%, most preferably 0.5 wt% to 1.0 wt%, based on the total weight of the composition.
[0067] Furthermore, it is also preferred that glyceryl stearate, glyceryl stearate SE and / or sodium stearoyl glutamate is contained as an emulsifier.
[0068] In the case of containing glyceryl stearate and / or glyceryl stearate SE, preferably, the total amount of these substances is in the range of 0.05 wt% to 1.0 wt% based on the total weight of the composition.
[0069] Furthermore, the composition according to the invention preferably comprises further short-chain polyols having 2 to 8 carbon atoms. Preferred polyols of this type are butanediol, glycerol, propylene glycol, pentanediol, butanediol, 1,2-hexanediol, 1,2-heptanediol, 1,2-propylene glycol, methylpropylene glycol and octanediol.
[0070] Preferably, these preferred polyols are contained in an amount of 0.1 wt% to 15 wt%, more preferably 1 wt% to 9 wt%, most preferably 1.5 wt% to 8 wt%, based on the total weight of the composition.
[0071] In a particularly preferred case, pentylene glycol is contained. In the case of containing pentylene glycol, in a preferred case, the total amount of pentylene glycol is in the range of 0.1 wt % to 4.0 wt %, more preferably 0.2 wt % to 3.0 wt %, most preferably 0.3 wt % to 2.5 wt %, based on the total weight of the composition.
[0072] For the case of containing caprylyl glycol, preferably, based on the total weight of the composition, the total amount of caprylyl glycol is in the range of 0.1 wt% to 5 wt%, more preferably 0.2 wt% to 2 wt%, most preferably 0.3 wt% to 1.5 wt%.
[0073] In a further preferred case, glycerol is contained. In the case of containing glycerol, preferably, the total amount of glycerol is in the range of 0.1 wt % to 15.0 wt %, more preferably 4.0 wt % to 13.0 wt %, most preferably 7.0 wt % to 12 wt %, based on the total weight of the composition.
[0074] In a further preferred aspect, the composition comprises phenoxyethanol, hydroxyacetophenone and / or ethylhexylglycerin.
[0075] In case of containing phenoxyethanol, preferably, the total amount of phenoxyethanol is in the range of 0.1 wt % to 0.8 wt % based on the total weight of the composition.
[0076] For the case of containing ethylhexylglycerin, preferably, the total amount of ethylhexylglycerin is in the range of 0.1 wt % to 1.2 wt % based on the total weight of the composition.
[0077] In the case of containing hydroxyacetophenone, preferably, the total amount of hydroxyacetophenone is in the range of 0.1 wt % to 0.5 wt % based on the total weight of the composition.
[0078] In a further preferred case, the total amount of water contained in the composition is in the range of 75.0 wt % to 95 wt %, for example 80 wt %, 85 wt % or 90 wt %, based on the total weight of the composition.
[0079] According to the present invention, in a preferred case, the viscosity of the composition is in the range of 300 to 1000 mPa·s.
[0080] According to the invention, additional active ingredients are also advantageously contained. They are advantageously selected from sodium hyaluronate, 1-methylhydantoin-2-imide, creatine, folic acid, panthenol, pantolactone, vitamin C, magnolia, calcium pantothenate and sodium ascorbyl phosphate. The active ingredients mentioned in the group are advantageously used in a total proportion of up to 10% by weight, preferably less than 1% by weight, based on the total weight of the composition.
[0081] The composition according to the invention may also comprise the ingredients customary in compositions of this type. DETAILED DESCRIPTION
[0082] The following examples illustrate the compositions of the present invention without limiting the invention to these examples. The values in the examples are weight percentages based on the total weight of the formulation.
[0083] Example 1 is a composition of the present invention. The other examples, namely, Example 2 and Example 3 are reference examples and are not within the scope of the present invention.
[0084] INCI Example 1 Example 2 Example 3 glycerin 11.0 11.0 11.0 Panthenol 5.0 5.0 5.0 Octyldodecanol 1.5 1.5 1.5 Xanthan gum 0.6 0.6 0.6 Hydroxyacetophenone 0.4 0.4 0.4 Pentylene glycol 0.31 0.31 0.31 Caprylyl glycol 0.3 0.3 0.3 Glyceryl Stearate SE 0.2 0.2 0.2 Ethylhexylglycerin 0.2 0.2 0.2 4-tert-Butyl cyclohexanol (trans isomer) 0.19 0 0.19 Sodium Hyaluronate 0.12 0.12 0.12 Sodium Stearoyl Glutamate 0.1 0.1 0.1 Citric Acid 0.046 0.046 0.046 Tocopherol 0.01 0.01 0.01 Ekdoin 0.3 0.3 0 water Add to 100 Add to 100 Add to 100 Viscosity, mPa·s 650 600 700 Pilling test results: Total pilling percentage 4% 6% 11% Pilling severity level L(2) L(3) L(6)
[0085] Pilling analysis is performed as follows:
[0086] Pilling test is conducted by a trained pilling panel with about 30 panelists, and each sample is tested twice.
[0087] Panelists washed their hands and arms with a standard cleanser, dried them, and applied 0.1 g of toner until fully absorbed.
[0088] Each panelist puts 0.1 g of the test preparation on his / her hand and rubs it into the skin until absorbed.
[0089] After absorption, panelists continued to massage for another 30 seconds.
[0090] Wait 60 seconds afterwards.
[0091] Follow with a second massage for another 30 seconds.
[0092] After the process, the skin was visually analyzed and the total number of pilling instances was recorded.
[0093] Pilling percentage = number of pilling cases / total number of test panel members × 100%.
[0094] According to another embodiment 4-embodiment 13 of the present invention:
[0095]
[0096]
[0097]
Claims
1. A cosmetic composition comprising an aqueous phase and an oil phase, and wherein based on the total weight of the composition, the composition comprises, a) 0.01% to 1% by weight of 4-tert-butyl cyclohexanol, b) 0.01% to 1.0% by weight of ectoine, c) 75.0% to 95% by weight of water, The composition contains no polymers polymerized from a mixture comprising or consisting of acrylic acid, methacrylic acid and / or vinyl pyrrolidone, and the composition contains no silicone oil.
2. The composition according to claim 1, characterized in that The total amount of 4-tert-butyl cyclohexanol ranges from 0.05 wt% to 1.0 wt%, preferably from 0.1 wt% to 0.8 wt%, more preferably from 0.15 wt% to 0.3 wt%, based on the total weight of the composition.
3. A composition according to any one of the preceding claims, characterised in that The composition comprises trans-4-tert-butyl cyclohexanol, and preferably, the total amount of trans-4-tert-butyl cyclohexanol is in the range of 0.05 wt% to 1.0 wt%, more preferably 0.1 wt% to 0.8 wt%, most preferably 0.15 wt% to 0.3 wt%, based on the total weight of the composition.
4. A composition according to any one of the preceding claims, characterised in that Contains cis-4-tert-butyl cyclohexanol and trans-4-tert-butyl cyclohexanol, wherein preferably, the weight ratio between cis-4-tert-butyl cyclohexanol and trans-4-tert-butyl cyclohexanol is in the range of 100:1 to 1:100, more preferably 10:1 to 1:99, most preferably 1:1 to 1:
98.
5. A composition according to any one of the preceding claims, characterised in that The total amount of ectoine is in the range of 0.05 wt % to 0.9 wt %, preferably 0.1 wt % to 0.8 wt %, more preferably 0.15 wt % to 0.4 wt %, based on the total weight of the composition.
6. A composition according to any one of the preceding claims, characterised in that The weight ratio between the total amount of 4-tert-butyl cyclohexanol and ectoine is in the range of 10:1 to 1:10, preferably 3:1 to 1:3, more preferably 1:1 to 1:
2.
7. A composition according to any one of the preceding claims, characterised in that The total amount of the oil phase in the cosmetic composition ranges from 0.1 wt% to 5.0 wt%, preferably from 0.2 wt% to 2.5 wt%, more preferably from 0.3 wt% to 2.0 wt%, based on the total weight of the composition.
8. A composition according to any one of the preceding claims, characterised in that The oil phase comprises at least one additional branched alcohol having 14 to 26 carbon atoms.
9. The composition according to claim 8, characterized in that The total amount of the at least one additional branched alcohol having 14 to 26 carbon atoms ranges from 0.1 wt% to 5.0 wt%, more preferably from 0.2 wt% to 2.0 wt%, most preferably from 0.3 wt% to 1.8 wt%, based on the total weight of the composition.
10. A composition according to any one of the preceding claims, characterised in that Octyldodecanol and / or hexyldecanol are contained, and preferably, based on the total weight of the composition, the total amount of alcohol selected from octyldodecanol and / or hexyldecanol is in the range of 0.1 wt % to 5.0 wt %, more preferably 0.2 wt % to 2.0 wt %, most preferably 0.3 wt % to 1.8 wt %.
11. A composition according to any one of the preceding claims, characterised in that The composition may also contain an oil compound other than silicone oil.
12. A composition according to any one of the preceding claims, characterised in that The composition comprises at least one gum selected from the group consisting of xanthan gum, gellan gum, sclerotium gum and dehydrogenated xanthan gum.
13. The composition according to claim 12, characterized in that The composition comprises 0.1 wt% to 1.5 wt%, preferably 0.15 wt% to 1.0 wt%, more preferably 0.3 wt% to 0.8 wt% of at least one polymer selected from xanthan gum, gellan gum, sclerotium gum and dehydroxanthan gum, based on the total weight of the composition.
14. Use of 4-tert-butyl cyclohexanol and ectoine in a cosmetic composition comprising an oil phase and an aqueous phase to reduce the pilling effect of the composition on human skin, wherein the composition preferably does not contain a polymer polymerized from a mixture comprising acrylic acid, methacrylic acid and / or vinyl pyrrolidone or consists of acrylic acid, methacrylic acid and / or vinyl pyrrolidone, and the composition does not contain silicone oil.
Citation Information
Patent Citations
Surface-active compositions, especially cosmetics, containing glycerol carbonate as emulsifier
DE19756454C1
Ectoin and ectoin derivatives as moisturizers in cosmetics
US20010021388A1
Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent
WO2009087242A2